OBJECTIVES To describe loss to follow-up (LTFU) at all stages of the HIV programme. DESIGN A retrospective cohort study. SETTING The HIV clinic at Hospital National Simão Mendes in Bissau, Guinea-Bissau. PARTICIPANTS A total of 4080 HIV-infected patients. OUTCOME MEASURES Baseline characteristics, percentages and incidence rates of LTFU as well as LTFU risk factors at four different sta...

purpose: to evaluate the success rate and complications of single-plate molteno tube implantation in patients with intractable glaucoma. methods: this study was conducted on records of patients who underwent molteno tube implantation from 1995 to 2000 and had at least 18 months of follow-up. results: thirty six eyes of 35 patients including 20 male and 15 female subjects with mean age of 29.7±2...

BACKGROUND High loss-to-follow-up rates are a risk in even the most rigorously designed randomized controlled trials (RCTs). Consequently, predicting and preventing loss to follow-up are important methodological considerations. We hypothesized that certain baseline characteristics are associated with a greater likelihood of patients being lost to follow-up. Our primary objective was to determin...

Background: The oncologic behavior of mucinous adenocarcinoma (MA) of colorectal differs from non-mucinous adenocarcinoma (NMA). MA is more advanced at diagnosis and has a poorer prognosis than NMA. We aimed to evaluate prognostic factors and survival rate in patients with MA compared with NMA in Western Iran. Methods: During 2008-2015 in a retrospective study, 83 patients with CRC referred to...

aim : the aim of this study was to provide quantitative estimations of the burden of death in term of years of life lost (yll) due to colorectal cancer (crc) in iran and a temporal trend analysis. background : colorectal cancer is the third most common cause of cancer-related deaths in the world. yll is a tool for quantifying the burden of disease according to mortality rates. the aim of this s...

INTRODUCTION Patients who are lost to follow-up (LTFU) while on antiretroviral therapy (ART) pose challenges to the long-term success of ART programs. We describe the extent to which patients considered LTFU are misclassified as true disengagement from care when they are still alive on ART and explain reasons for ART discontinuation using our active tracing program to further improve ART retent...